HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosisYoshiteru Miyauchi, Takeshi Miyamoto, Shigeaki Kato et al.|Proceedings of the National Academy of Sciences|2013Cited by 181
Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cellsHiroya Miyamoto, Takeshi Miyamoto, Takayuki Suzuki et al.|Journal of Bone and Mineral Research|2012Cited by 174
Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesisHiroko Hoshi, Takeshi Miyamoto, Hao Wu et al.|Journal of Bone and Mineral Research|2012Cited by 79
TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated stateTakahiro Mori, Takeshi Miyamoto, Yuzo Sato et al.|Oncogene|2013Cited by 62
Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitorsHiroya Kanagawa, Takeshi Miyamoto, Ritsuko Masuyama et al.|Journal of Bone and Mineral Metabolism|2015Cited by 51